Molina Healthcare (NYSE:MOH) Stock Rating Lowered by Wall Street Zen

Molina Healthcare (NYSE:MOH) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday.

Other analysts also recently issued research reports about the company. Mizuho cut their price target on Molina Healthcare from $400.00 to $330.00 and set an “outperform” rating on the stock in a research note on Friday, July 11th. Cantor Fitzgerald cut their target price on Molina Healthcare from $210.00 to $180.00 and set a “neutral” rating on the stock in a research note on Friday. Truist Financial set a $175.00 target price on Molina Healthcare in a research note on Friday. Robert W. Baird cut their target price on Molina Healthcare from $373.00 to $179.00 and set a “neutral” rating on the stock in a research note on Friday, July 25th. Finally, Sanford C. Bernstein cut their target price on Molina Healthcare from $284.00 to $220.00 and set an “outperform” rating on the stock in a research note on Friday, September 5th. Three investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $203.64.

Molina Healthcare Stock Performance

Molina Healthcare stock opened at $163.16 on Friday. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.92. The company has a market capitalization of $8.84 billion, a P/E ratio of 10.10 and a beta of 0.55. The stock’s 50 day moving average is $184.20 and its 200 day moving average is $237.98. Molina Healthcare has a twelve month low of $151.95 and a twelve month high of $359.97.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, October 22nd. The company reported $1.84 earnings per share for the quarter, missing the consensus estimate of $3.97 by ($2.13). The company had revenue of $11.48 billion during the quarter, compared to analysts’ expectations of $10.99 billion. Molina Healthcare had a return on equity of 22.95% and a net margin of 1.98%.The business’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.01 EPS. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. On average, equities research analysts predict that Molina Healthcare will post 24.4 earnings per share for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other news, COO James Woys purchased 10,000 shares of the stock in a transaction dated Monday, August 4th. The shares were purchased at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the acquisition, the chief operating officer directly owned 74,331 shares of the company’s stock, valued at $11,591,176.14. This represents a 15.54% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Ronna Romney sold 700 shares of the stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total value of $107,618.00. Following the transaction, the director directly owned 17,131 shares in the company, valued at $2,633,719.94. The trade was a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.26% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Molina Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of the company. Iridian Asset Management LLC CT bought a new position in shares of Molina Healthcare during the 3rd quarter valued at $1,829,000. Oregon Public Employees Retirement Fund lifted its holdings in shares of Molina Healthcare by 34.7% during the 3rd quarter. Oregon Public Employees Retirement Fund now owns 6,223 shares of the company’s stock valued at $1,191,000 after buying an additional 1,602 shares during the period. State of Alaska Department of Revenue raised its holdings in Molina Healthcare by 26.7% in the 3rd quarter. State of Alaska Department of Revenue now owns 16,500 shares of the company’s stock worth $3,156,000 after purchasing an additional 3,475 shares during the period. Nisa Investment Advisors LLC raised its holdings in Molina Healthcare by 41.3% in the 3rd quarter. Nisa Investment Advisors LLC now owns 11,786 shares of the company’s stock worth $2,255,000 after purchasing an additional 3,443 shares during the period. Finally, Venturi Wealth Management LLC bought a new position in Molina Healthcare in the 3rd quarter worth $206,000. 98.50% of the stock is owned by institutional investors.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.